Takeda completes $62bn acquisition of Irish biotech firm Shire

This article was originally published here

The cash-cum-stock deal between Takeda and Shire was signed in May 2018 in a move to create a global, values-based research and development (R&D) driven biopharma company headquartered

The post Takeda completes $62bn acquisition of Irish biotech firm Shire appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply